STOCK TITAN
  1. Home
  2. Sec-filings
  3. ADAP
  4. [8-K] Adaptimmune Therapeutics plc American Reports Material Event

[8-K] Adaptimmune Therapeutics plc American Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock ADAP logo
Adaptimmune Therapeutics Plc

NASDAQ:ADAP

ADAP Rankings

#6928 Ranked by Market Cap
N/A Ranked by Dividends
#114 Top Loser

ADAP Latest News

May 13, 2025
Adaptimmune Reports Q1 Financial Results and Provides Business Update
May 7, 2025
Adaptimmune to Report Q1 2025 Financial and Business Updates on Tuesday, May 13, 2025
Mar 20, 2025
Adaptimmune Provides Q4 and Full Year 2024 Business Update
Mar 12, 2025
Adaptimmune to Report Full Year and Q4 2024 Financial and Business Updates on Thursday, March 20, 2025
Jan 30, 2025
Adaptimmune to Participate in the Guggenheim Securities SMID Cap Biotech Conference February 6, 2025

ADAP Stock Data

72.70M
263.38M
0.31%
49.85%
2.48%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United Kingdom
ABINGDON, OXFORDSHIRE